Idorsia Ltd
General ticker "IDRSF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.4B (TTM average)
Idorsia Ltd follows the US Stock Market performance with the rate: 40.5%.
Estimated limits based on current volatility of 0.4%: low 4.94$, high 4.98$
Short-term IDRSF quotes
Long-term IDRSF plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | CHF97.10MM | CHF152.39MM | CHF112.51MM |
| Operating Expenses | CHF900.07MM | CHF407.53MM | CHF344.52MM |
| Operating Income | CHF-802.97MM | CHF-255.15MM | CHF-232.01MM |
| Non-Operating Income | CHF-17.12MM | CHF-39.11MM | CHF-31.31MM |
| Interest Expense | CHF17.17MM | CHF20.67MM | CHF20.12MM |
| R&D Expense | CHF383.33MM | CHF293.56MM | CHF143.67MM |
| Income(Loss) | CHF-820.09MM | CHF-294.25MM | CHF-263.32MM |
| Taxes | CHF7.81MM | CHF3.67MM | CHF0.43MM |
| Net Income(Loss)* | CHF-827.90MM | CHF-297.92MM | CHF-263.76MM |
| Stockholders Equity | CHF-660.96MM | CHF-968.72MM | CHF-1,212.14MM |
| Inventory | CHF35.84MM | CHF59.15MM | CHF62.65MM |
| Assets | CHF904.18MM | CHF500.00MM | CHF505.89MM |
| Operating Cash Flow | CHF-859.11MM | CHF-629.30MM | CHF-370.23MM |
| Capital expenditure | CHF27.06MM | CHF9.40MM | CHF17.99MM |
| Investing Cash Flow | CHF743.90MM | CHF632.61MM | CHF305.06MM |
| Financing Cash Flow | CHF162.31MM | CHF-0.20MM | CHF26.11MM |
| Earnings Per Share** | CHF-4.67 | CHF-1.67 | CHF-1.45 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.